India's Decade of Collaboration
Harvard Business Review
MAY 31, 2011
Biocon's core competency lies in building and orchestrating global innovation networks — the cornerstone of a polycentric innovation model. In this fluid system, Biocon finances CMI's inventive R&D, while using the funds from the Pfizer deal to finance its own R&D and go-to-market activities.
13 
Let's personalize your content